Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M38.2Revenue $M1.1Net Margin (%)-1,441.6Z-Score-13.6
Enterprise Value $M33.1EPS $-0.3Operating Margin %-1,601.3F-Score2
P/E(ttm))0Cash Flow Per Share $-0.1Pre-tax Margin (%)-1,441.4Higher ROA y-yN
Price/Book15.810-y EBITDA Growth Rate %0Quick Ratio1.9Cash flow > EarningsY
Price/Sales29.45-y EBITDA Growth Rate %0Current Ratio2.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-117.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)5ROE % (ttm)-204.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M61.1ROI % (ttm)-161.1Gross Margin Increase y-yN

Gurus Latest Trades with NBY

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

NBY is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NBY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SIECZKAREK MARK MDirector 2015-03-03Buy166,666$0.65 view
Pioneer Pharma (Singapore) Pte10% Owner 2015-03-03Buy2,590,000$0.65 view
Najafi RaminChairman 2015-03-03Buy166,666$0.65 view
Najafi RaminChairman 2014-12-12Buy50,000$0.65-3.08 view
PAULSON THOMAS JCFO 2014-12-12Buy10,000$0.68-7.35 view
Stroman David W.SVP, Ophthalmic Product Devt. 2014-12-12Buy10,000$0.66-4.55 view
Najafi RaminChairman 2014-12-11Buy20,000$0.65 view
PAULSON THOMAS JCFO 2014-12-09Buy10,000$0.67-5.97 view
Najafi RaminChairman 2014-12-05Buy25,000$0.65-3.08 view
Wicks Tony D.S.Director 2014-12-02Sell20,000$0.7-10 view

Press Releases about NBY :

    Quarterly/Annual Reports about NBY:

    News about NBY:

    Articles On GuruFocus.com
    Own it Feb 29 2012 
    NovaBay Pharmaceuticals Inc. (NBY) Chairman Ramin Najafi buys 1,000 Shares Aug 28 2009 
    NovaBay Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results Aug 14 2009 

    More From Other Websites
    NovaBay Pharmaceuticals Announces the Effectiveness of SEC Registration Statement Apr 21 2015
    NovaBay Pharmaceuticals Announces the Effectiveness of SEC Registration Statement Apr 21 2015
    NovaBay Signs Distribution Agreement with AmerisourceBergen Corporation for Avenova Apr 16 2015
    NovaBay Signs Distribution Agreement with AmerisourceBergen Corporation for Avenova Apr 16 2015
    NovaBay Pharmaceuticals Appoints Mark M. Sieczkarek Chairman Apr 14 2015
    NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Apr 14 2015
    NovaBay Pharmaceuticals Appoints Mark M. Sieczkarek Chairman Apr 14 2015
    NovaBay Pharmaceuticals to Offer Educational Workshop on Eye Lid Management at the ASCRS Annual... Apr 10 2015
    NovaBay Pharmaceuticals to Offer Educational Workshop on Eye Lid Management at the ASCRS Annual... Apr 10 2015
    NeutroPhase Was Named as the Official Wound Cleanser of the NNFF Apr 01 2015
    NOVABAY PHARMACEUTICALS, INC. Financials Mar 31 2015
    NovaBay Pharmaceuticals Reports 2014 Fourth Quarter and Full Year Financial Results and Provides... Mar 26 2015
    NovaBay Pharmaceuticals Reports 2014 Fourth Quarter and Full Year Financial Results and Provides... Mar 26 2015
    NovaBay's Unique Eye Care Product Has $500 Million Market Potential, Says NovaBay VP in Stock-Sector... Mar 26 2015
    Q4 2014 NovaBay Pharmaceuticals Inc Earnings Release - After Market Close Mar 26 2015
    NovaBay’s Avenova Featured in Ophthalmology Management Mar 24 2015
    NovaBay’s Avenova Featured in Ophthalmology Management Mar 24 2015
    NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Mar 24 2015
    The National Necrotizing Fasciitis Foundation Names NovaBay's NeutroPhase as its Official "Flesh... Mar 17 2015
    NovaBay Pharmaceuticals Provides Update on Avenova Sales Growth Mar 16 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK